PS1 Fat fate and disease - from science to global policy
Peter Gluckman
Office of Chief Science Advsor to the Prime Minister
PS2 Bone Fragility in Children - Genes and Treatments
Frank Rauch
Shriners Hospitals for Children
PS3 Unique Newly Discovered Muse Cells May Lead to the Paradigm Shift of Stem Cell Therapy
Mari Dezawa
Department of Stem Cell Biology and History & Department of Anatomy and Anthropology, Tohoku University Graduate School of Medicine
PS4 RASopathy - from molecular mechanism to clinical practice
Yoichi Matsubara
National Center for Child Health and Development
SY1-1 Growth: New era of growth disorders
How to approach growth disorders: genetics for better clinical care
Andrew Dauber
Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children fs Hospital Medical Center
SY1-2 Growth: New era of growth disorders
IGF2 mutation in Silver-Russell syndrome
Thomas Eggermann
Institute of Human Genetics, University Hospital, Aachen Technical
SY1-3 Growth: New era of growth disorders
Treatment Strategies for Short Stature in Achondroplasia
Hiroshi Kitoh
Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine
SY2-1 Puberty: Mechanisms and disorders of puberty
Neuroendocrine mechanism regulating puberty onset
Hiroko Tsukamura
Nagoya University
SY2-2 Puberty: Mechanisms and disorders of puberty
Central precocious puberty caused by mutations in the imprinted gene MKRN3
Ana Paula Abreu
Universidade de Sao Paulo/ Brigham and Women's Hospital
SY2-3 Puberty: Mechanisms and disorders of puberty
Mechanisms of pubertal growth spurt and growth plate closure
Kye Shik Shim
Kyung Hee University Hospital at Gangdong
SY3 Iodine deficiency disorders
Somchit Jaruratanasirikul
Songkla University
SY3-2 Thyroid: Management of thyroid disorders
The long term outcome of subclinical congenital hypothyroidism
Sarah Mathai
Department of Pediatrics, Christian Medical College
SY3-3 Thyroid: Management of thyroid disorders
Management of autoimmune thyroiditis
Andrew Bauer
The Children's Hospital of Philadelphia; Perelman School of Medicine, The University of Pennsylvania
SY4-1 New Strategy
Next-generation sequencing and array-based comparative genomic hybridization for patients with pediatric endocrine disorders
Maki Fukami
National Research Institute for Child Health and Development
SY4-2 New Strategy
Generating Functional Miniature Organs (Organoids) in a Dish
Hidenori Akutsu
Department of Reproductive Medicine, National Research Institute for Child Health and Development
SY4-3 New Strategy
Clinical steroid mass spectrometry and metabolomics
Cedric HL Shackleton
Institute of Metabolism and systems research (IMSR), University of Birmingham / UCSF Benioff Children fs Hospital Oakland Research Institute
SY5-1 Obesity: Increasing risk of morbidity in children and adolescents
The role of MC4R in pediatric obesity: above and beyond the central nervous system
Feihong Luo
Deparment of Pediatric Endocrinology and Inborn Metabolic Diseases, Shanghai, China
SY5-2 Obesity: Increasing risk of morbidity in children and adolescents
Management of hypothalamic obesity
Mitchell Eugene Geffner
Keck School of Medicine of USC
SY5-3 Obesity: Increasing risk of morbidity in children and adolescents
Determinants, consequences and prevention of childhood overweight and obesity
Muhammad Yazid Jalaludin
Department of Paediatrics, Faculty of Medicine, University Malaya
SY6-1 Which is most dangerous for future cognition in young children with diabetes: hypo- or hyperglycemia?
Diabetes dysglycaemia, cognition and the developing brain
Fergus Cameron
Royal Children fs Hospital
SY6-2 Which is most dangerous for future cognition in young children with diabetes: hypo- or hyperglycemia?
Improving metabolic control without increasing severe hypoglycemia
Karin Åkesson
National Swedish Padiatric Diabetes Registry
SY6-3 Which is most dangerous for future cognition in young children with diabetes: hypo- or hyperglycemia?
Closed loop systems to avoid extreme hypo- and hyperglycemia
Martin de Bock
Princess Margaret Hospital
SY7-1 DSD: Variations in Sex Development and in Gender Identity
Initial approach to Disorders of Sexual Differentiation
Kah Yin Loke
National University of Singapore
SY7-2 DSD: Variations in Sex Development and in Gender Identity
Long-term outcome of early surgical intervention for hypospadias; What happens at Puberty?
Kimihiko Moriya
Department of Renal and Genitourinary Surgery, Hokkaido University
SY7-3 DSD: Variations in Sex Development and in Gender Identity
Transgender Youth: Current Concepts, Management, and Priorities for Research
Stephen Rosenthal
Division of Pediatric Endocrinology, Child and Adolescent Gender Center, University of California, San Francisco
SY8-1 Workshop on Developing countries
A report on the first year of the APPES-CLAN Equity Working Group. Where to from here? What can you do to help?
Kate Armstrong
President & Founder, CLAN (Caring & Living As Neighbours)
-
Affordable access to medicines and equipment
-
Education, research and advocacy
-
Optimal medical management
-
Encouragement of family support groups and
-
Reducing financial burdens on families.
SY8-2 Workshop on Developing countries
Challenges for Pediatric Endocrinology in a resource constrained environment
Syed Jamal Raza
National Institute of Child Health
SY8-3 Workshop on Developing countries
Building Newborn Screening Systems
Dianne Webster
Newborn Metabolic Screening Programme / Antenatal Screening for Down Syndrome & Other Conditions
SY9-1 Hot topics
Epigenetics as the mediator of gene:environment interactions and programming of non-communicable disease
Richard Saffery
Murdoch Childrens Research Insitute and Department of Pediatrics, University of Melbourne
SY9-2 Hot topics
Obesity and Brain Insulin Resistance: Cause of Consequence
Hans-Ulrich Häring
Department of Internal Medicine IV, University Hospital Tübingen
SY9-3 Hot topics
MIRAGE Syndrome: A New Adrenal hypoplasia Syndrome Caused by Heterozygous SAMD9 Mutations
Naoko Amano
Department of Pediatrics, Keio University School of Medicine Department of Pediatrics, Saiseikai Central Hospital
MTE1 Bone
Pediatric Osteoporosis
Craig Munns
The Children's Hospital at Westmead
-
Two or more long bone fractures by age 10 yr
-
Three or more long bone fractures at any age up to 16 yr.
MTE2 Endocrine Imaging
The state-of-the-art applications of PET in endocrinology
Tohru Yorifuji
Endocrinology and Metabolism, Children's Medical Center, Osaka City General Hospital
MTE3 Growth & Genetics
Genetic Approaches to make a Diagnosis in Short Stature
Peter Clayton
Faculty of Biology, Medicine & Health, University of Manchester
MTE4 Growth
New data on long-term safety of GH treatment in SGA
AnitaHokken-Koelega
Erasmus University Medical Center
MTE5 Water and electrolytes
Management of water and electrolytes imbalance
Joseph Majzoub
Boston Children's Hospital, Harvard Medical School
-
To understand how to treat a patient with diabetes insipidus or SIADH with combinations of fluid and AVP or DDAVP, without causing hyper- or hypo-natremia. When AVP/DDAVP is high (anti-diuretic state), a patient can only tolerate 1/10th as much fluid as when vasopressin/DDAVP is low (diuretic state).
-
To diagnose cause of polyuria: central diabetes insipidus versus primary increased fluid intake
-
To use measurement of blood copeptin instead of AVP
-
To diagnose cause of hyponatremia: dehydration/reduced intravascular volume versus SIAD
-
To treat diabetes insipidus in neonates without causing hyponatremia
MTE6 Adrenals
Diagnosis and Management of CAH
Toshihiro Tajima
Jichi Children's Medical Center Tochigi
MTE7 Thyroid
Medical and Surgical Management of Pediatric Thyroid Nodules and Cancer
Andrew Bauer1,2, Ken Kazahaya3,4
1The Children's Hospital of Philadelphia; 2Perelman School of Medicine, The University of Pennsylvania; 3Division of Pediatric Otolaryngology, The Children's Hospital of Philadelphia; 4Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania
ATA Pediatric Risk Level | Definition | Initial Post-operative Staging |
---|---|---|
Low | Disease confined to the thyroid with minimal level VI lymph node metastasis | TSH suppressed Tg at 3 month intervals with neck ultrasound at 6 months |
Intermediate | Extrathyroidal extension with extensive level VI or lateral neck lymph node metastasis | TSH-stimulated Tg and diagnostic 123I whole body scan |
High | Regionally extensive disease with or without distant metastasis | TSH-stimulated Tg and diagnostic 123I whole body scan |
LS9 New Genetic Causes of Short Stature: A Primer for Endocrinologists
Andrew Dauber
Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center
LS10 Current Status of the long-term Safety of GH Treatment
Peter Clayton
Faculty of Biology, Medicine & Health, University of Manchester
LS11 How GH treatment changes the phenotype of children with Prader Willi Syndrome
Anita Hokken-Koelega
Erasmus University Medical Center
LS12 Safety and Efficacy of PEG-rhGH in Growth Hormone Deficiency Children: Results of Multicenter Clinical Studies in China
Pinchas Cohen1, Xiaoping Luo2
1SC Leonard Davis School of Gerontology; 2Chinese Society of Pediatric Endocrinology and Metabolism / Department of Pediatrics, Tongji Hospital, Tongji Medical College of Huazhong University of Sciense & Technology
LS13 Moving Towards an International Consensus on the Future of GH therapy
Pinchas Cohen
USC Leonard Davis School of Gerontology
LS14 When one gene does it all: monogenic forms of autoimmune diabetes
Elisa De Franco
Naomi Berrie Fellow in Diabetes Research, Molecular Genetics, University of Exeter Medical School
LS15 African Efe Pygmies: From Anthropology to Endocrinology
Mitchell E. Geffner
Keck School of Medicine of USC, Center for Endocrinology, Diabetes & Metabolism, Children's Hospital Los Angeles
LS16 Skeletal, Growth, and Functional Improvements in Children with Hypophosphatasia Treated with Asfotase Alfa for 5 years
Jill H Simmons
Vanderbilt University School of Medicine
ES1-1 Total management of Rickets: causes, prevention and treatment
Global Consensus Recommendations on Prevention and Management of Nutritional Rickets: Definition and Diagnosis
Lorna Ramos-Abad
University of the Philippines College of Medicine, Philippine General Hospital Metro Manila
ES1-2 Total management of Rickets: causes, prevention and treatment
Global Consensus Recommendations on Prevention and Management of Nutritional Rickets
Navoda Atapattu
Consultant Paediatric Endocrinologist
ES1-3 Total management of Rickets: causes, prevention and treatment
Hypophosphatemic Rickets: Current Status and Future Perspectives
Toshimi Michigami
Department of Bone and Mineral Metabolism, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo-cho, Izumi, Osaka Japan
ES2 Adrenarche
Adrenarche
Joseph Majzoub
Royal Children's Hospital
-
To understand the changes that occur in 17, 20 lyase and 3 β HSD2 enzyme activities during adrenarche
-
To understand changes in the zona reticularis during adrenarche
-
To understand how to identify true, genetic 3 β HSD2 deficiency
-
To understand whether mild, nonclassical 3 β HSD2 exists
-
To discuss the possible role of intracrine, intra-adrenal cortisol in the onset of adrenarche
-
To speculate on why benign premature adrenarche is associated with obesity